A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2

NCT05737940 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Hypertension (World Health Organization Group 2)
Heart Failure

Interventions

DRUG: AZD3427
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]